Addus HomeCare Co. (NASDAQ:ADUS) Shares Sold by Mutual of America Capital Management LLC

Mutual of America Capital Management LLC cut its position in Addus HomeCare Co. (NASDAQ:ADUS) by 1.3% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 57,842 shares of the company’s stock after selling 777 shares during the period. Mutual of America Capital Management LLC owned approximately 0.32% of Addus HomeCare worth $7,695,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of the company. Vanguard Group Inc. increased its holdings in shares of Addus HomeCare by 1.5% in the first quarter. Vanguard Group Inc. now owns 1,276,467 shares of the company’s stock valued at $131,910,000 after purchasing an additional 19,027 shares during the period. Point72 Asset Management L.P. increased its holdings in shares of Addus HomeCare by 73.4% in the second quarter. Point72 Asset Management L.P. now owns 745,824 shares of the company’s stock valued at $86,598,000 after purchasing an additional 315,602 shares during the period. Dimensional Fund Advisors LP boosted its stake in shares of Addus HomeCare by 0.8% in the second quarter. Dimensional Fund Advisors LP now owns 714,253 shares of the company’s stock worth $82,930,000 after buying an additional 5,421 shares during the last quarter. Principal Financial Group Inc. boosted its stake in shares of Addus HomeCare by 17.5% in the third quarter. Principal Financial Group Inc. now owns 505,853 shares of the company’s stock worth $67,293,000 after buying an additional 75,409 shares during the last quarter. Finally, WCM Investment Management LLC boosted its stake in shares of Addus HomeCare by 2.9% in the third quarter. WCM Investment Management LLC now owns 498,279 shares of the company’s stock worth $65,250,000 after buying an additional 13,938 shares during the last quarter. 95.35% of the stock is owned by institutional investors and hedge funds.

Addus HomeCare Price Performance

NASDAQ ADUS opened at $118.27 on Tuesday. The company has a market cap of $2.14 billion, a PE ratio of 27.06, a price-to-earnings-growth ratio of 2.09 and a beta of 1.04. The stock’s 50 day simple moving average is $128.82 and its 200-day simple moving average is $122.73. Addus HomeCare Co. has a 1-year low of $85.43 and a 1-year high of $136.12.

Addus HomeCare (NASDAQ:ADUS) last released its earnings results on Monday, November 4th. The company reported $1.30 earnings per share for the quarter, beating the consensus estimate of $1.28 by $0.02. The business had revenue of $289.80 million for the quarter, compared to the consensus estimate of $289.42 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The business’s quarterly revenue was up 7.1% compared to the same quarter last year. During the same quarter last year, the business posted $1.03 earnings per share. On average, equities research analysts anticipate that Addus HomeCare Co. will post 4.58 EPS for the current fiscal year.

Wall Street Analyst Weigh In

ADUS has been the topic of a number of recent research reports. Stephens upped their target price on Addus HomeCare from $143.00 to $145.00 and gave the stock an “overweight” rating in a research note on Wednesday, November 6th. Oppenheimer upped their target price on Addus HomeCare from $140.00 to $145.00 and gave the stock an “outperform” rating in a research note on Monday, September 23rd. Macquarie restated an “outperform” rating and issued a $139.00 target price on shares of Addus HomeCare in a research note on Monday, November 4th. KeyCorp initiated coverage on Addus HomeCare in a research note on Friday, October 11th. They issued an “overweight” rating and a $150.00 target price on the stock. Finally, Royal Bank of Canada restated an “outperform” rating and issued a $136.00 target price on shares of Addus HomeCare in a research note on Thursday, November 14th. One analyst has rated the stock with a sell rating, eight have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $131.63.

Insider Activity at Addus HomeCare

In related news, Director Esteban Lopez sold 500 shares of the stock in a transaction that occurred on Wednesday, September 4th. The stock was sold at an average price of $130.03, for a total value of $65,015.00. Following the completion of the sale, the director now owns 3,866 shares of the company’s stock, valued at approximately $502,695.98. This trade represents a 11.45 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Michael D. Wattenbarger sold 21,917 shares of the firm’s stock in a transaction on Monday, August 26th. The stock was sold at an average price of $133.29, for a total value of $2,921,316.93. Following the sale, the executive vice president now directly owns 7,215 shares of the company’s stock, valued at approximately $961,687.35. This trade represents a 75.23 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 22,917 shares of company stock valued at $3,050,082. 4.60% of the stock is currently owned by insiders.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.